Qube-Research--Technologies

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
2,819
Total Value
42368360846
Accession Number
0001729829-25-000048
Form Type
13F-HR
Manager Name
Qube-Research--Technologies
Data Enrichment
80% identified
2,245 identified574 unidentified

Holdings

2,819 positions • $42.4B total value
Manager:
Search and click to pin securities to the top
Page 122 of 141
464286814
Shares:1.8K
Value:$85.3K
% of Portfolio:0.0% ($85.3K/$42.4B)
Gold Royalty Corp.
Shares:58.7K
Value:$84.5K
% of Portfolio:0.0% ($84.5K/$42.4B)
25460E661
Shares:2.7K
Value:$83.0K
% of Portfolio:0.0% ($83.0K/$42.4B)
05479K106
Shares:32.4K
Value:$82.0K
% of Portfolio:0.0% ($82.0K/$42.4B)
OnKure Therapeutics, Inc.
Shares:18.7K
Value:$80.3K
% of Portfolio:0.0% ($80.3K/$42.4B)
92206C730
Shares:316
Value:$80.2K
% of Portfolio:0.0% ($80.2K/$42.4B)
TriplePoint Venture Growth BDC Corp.
Shares:11.4K
Value:$79.8K
% of Portfolio:0.0% ($79.8K/$42.4B)
SKYX Platforms Corp.
Shares:70.0K
Value:$79.8K
% of Portfolio:0.0% ($79.8K/$42.4B)
46434G822
Shares:1.2K
Value:$79.5K
% of Portfolio:0.0% ($79.5K/$42.4B)
Ondas Holdings Inc.
Shares:74.2K
Value:$79.4K
% of Portfolio:0.0% ($79.4K/$42.4B)
Autolus Therapeutics plc
Shares:51.2K
Value:$79.3K
% of Portfolio:0.0% ($79.3K/$42.4B)
GENELUX Corp
Shares:29.1K
Value:$78.5K
% of Portfolio:0.0% ($78.5K/$42.4B)
Cytek Biosciences, Inc.
Shares:19.6K
Value:$78.5K
% of Portfolio:0.0% ($78.5K/$42.4B)
808524607
Shares:3.3K
Value:$78.1K
% of Portfolio:0.0% ($78.1K/$42.4B)
Inhibikase Therapeutics, Inc.
Shares:35.6K
Value:$78.0K
% of Portfolio:0.0% ($78.0K/$42.4B)
316092824
Shares:1.3K
Value:$77.6K
% of Portfolio:0.0% ($77.6K/$42.4B)
BAYTEX ENERGY CORP.
Shares:34.8K
Value:$77.2K
% of Portfolio:0.0% ($77.2K/$42.4B)
KOREA ELECTRIC POWER CORP
Shares:10.4K
Value:$77.0K
% of Portfolio:0.0% ($77.0K/$42.4B)
UNIFI INC
Shares:16.0K
Value:$76.8K
% of Portfolio:0.0% ($76.8K/$42.4B)
652941105
Shares:24.3K
Value:$76.7K
% of Portfolio:0.0% ($76.7K/$42.4B)